Bupropion HCL ER
SPE2D2-21-R-0105 · DEPT OF DEFENSE
A PHARMACEUTICAL PREPARATION MANUFACTURING solicitation, with responses due 2022-02-15. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
Modification P00008 SPE2D223D0002 is issued to invoke option year 3 for Bupropion HCL ER National Contract. Modification P00007 SPE2D223D0002 is issued in accordance with DoD Class Deviation 2025-O0003 and Class Deviation 2025-O0004 into subject solicitation. Modification P00006 SPE2D223D0002 is iss
Comparable recent awards in PHARMACEUTICAL PREPARATION MANUFACTURING
| Winner | Award value | Offers | Date |
|---|---|---|---|
| THERACOM, L.L.C. | $38K | 1 | 2026-07-02 |
| REGIMED MEDICAL | $293K | 7 | 2026-07-02 |
| SRI INTERNATIONAL | $49.9M | 7 | 2026-07-02 |
| PRIORITY HEALTHCARE DISTRIBUTION INC | $16K | 1 | 2026-07-02 |
| COVERMYMEDS PHARMACY LLC | $16K | 1 | 2026-07-02 |
Questions
What is solicitation SPE2D2-21-R-0105?
Bupropion HCL ER, issued by DEPT OF DEFENSE, under NAICS 325412 (PHARMACEUTICAL PREPARATION MANUFACTURING). Responses are due 2022-02-15.
What do similar contracts close for?
Comparable closed awards in this category ran from $16K to $49.9M, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.
Explore the market
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
Closed awards from public federal data, not the forecast. One email, no account.
Or get the forecast for this solicitation — $49, one report.